Literature DB >> 2949967

Chronic bioassays of chlorinated humic acids in B6C3F1 mice.

B L Van Duuren, S Melchionne, I Seidman, M A Pereira.   

Abstract

Humic acids (Fluka), chlorinated to carbon:chlorine (C:Cl) ratios of 1:1 and 1:0.3, were administered to B6C3F1 mice, 50 males and 50 females per group, in the drinking water at a total organic carbon (TOC) level of 0.5 g/L. The mice were 6 to 8 weeks old at the beginning of the bioassays. The doses used were based on short-term (8 weeks) evaluations for toxicity, palatability, and weight gain. The chronic bioassays included the following control groups: unchlorinated humic acids (0.5 g/L), no-treatment (100 males and 100 females), dibromoethane (DBE, 2.0 mM in drinking water; positive control) and 0.44% sodium chloride in drinking water, i.e., at the same concentration as those receiving chlorinated humic acids. The chlorinated humic acids were prepared freshly and chemically assayed once per week. All chemicals were, with the exception of DBE, administered for 24 months; DBE was administered for 18 months. The volumes of solutions consumed were measured once weekly. All treatment groups showed normal weight gain except the DBE group. At the completion of exposure, the animals were sacrificed and necropsied, and tissue sections were taken for histopathology. No markedly significant increases in tumor incidences were evident in any of the organs and tissues examined in the chlorinated humic acid groups compared to unchlorinated humic acids and the no-treatment control groups. DBE caused the expected high incidence of squamous carcinomas of the forestomach. The chlorinated humic acids tested contained direct-acting alkylating agents, based on their reactivity with p-nitrobenzylpyridine (PNBP), and showed mutagenic activity in S. typhimurium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2949967      PMCID: PMC1474334          DOI: 10.1289/ehp.8669109

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

1.  Carcinogenicity bioassays of vinyl chloride: current results.

Authors:  C Maltoni; G Lefemine
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

2.  Oncogenic response of rat skin, lungs, and bones to vinyl chloride.

Authors:  P L Viola; A Bigotti; A Caputo
Journal:  Cancer Res       Date:  1971-05       Impact factor: 12.701

3.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

4.  Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice.

Authors:  J M Ward; D G Goodman; R A Squire; K C Chu; M S Linhart
Journal:  J Natl Cancer Inst       Date:  1979-09       Impact factor: 13.506

5.  History, survival, and growth patterns of B6C3F1 mice and F344 rats in the National Cancer Institute Carcinogenesis Testing Program.

Authors:  T P Cameron; R L Hickman; M R Kornreich; R E Tarone
Journal:  Fundam Appl Toxicol       Date:  1985-06

6.  Formation of mutagens following chlorination of humic acid. A model for mutagen formation during drinking water treatment.

Authors:  J R Meier; R D Lingg; R J Bull
Journal:  Mutat Res       Date:  1983-07       Impact factor: 2.433

7.  A carcinogenicity study with mutagenic organic concentrates of drinking-water in the Netherlands.

Authors:  H J Kool; F Kuper; H van Haeringen; J H Koeman
Journal:  Food Chem Toxicol       Date:  1985-01       Impact factor: 6.023

8.  Carcinogenicity bioassays of bromoacetaldehyde and bromoethanol--potential metabolites of dibromoethane.

Authors:  B L Van Duuren; I Seidman; S Melchionne; S A Kline
Journal:  Teratog Carcinog Mutagen       Date:  1985

9.  Use of biological assay systems to assess the relative carcinogenic hazards of disinfection by-products.

Authors:  R J Bull; M Robinson; J R Meier; J Stober
Journal:  Environ Health Perspect       Date:  1982-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.